# Sonendo

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/sonendo

- Industry: Healthcare Specialists
- Headquarters: Laguna Hills, US
- Website: www.sonendo.com
- Total disclosed funding: $191M
- Latest round: Series E (Dec 10, 2019)
- Investors on record: 17

## About

Based in California, US, and founded in 2006 by its CEO, Bjarne Bergheim, Sonendo, Inc. operates as a provider and developer of dental care technologies that offer root canal therapy services. In January 2020, Sonendo, Inc. raised USD 85 million in funding led by EW Healthcare Partners, with ArrowMark Partners, Broadfin Capital, NeoMed, and Redmile Group, CVF Capital Partners, General Atlantic, JMR Capital Partners, Meritech Capital Partners, OrbiMed Advisors, Perceptive Advisors, SEB Private Equity, and Security Pacific Finance. In October 2021, Sonendo, Inc. raised USD 93.6 million in an IPO, selling 7.8 million shares at USD 12 per share on the New York Stock Exchange under the ticker symbol SONX. As of November 2021, the company has treated 700,000 patients with the GentleWave Procedure.

Sonendo, Inc. offers the GentleWave® System, which helps doctors reach lateral canals and microscopic tubules to remove tissue, debris, biofilm, and bacteria. SoundFlow® provides an efficient and effective fluid delivery process, and SoundBAR® combines macro and microscopic cleaning.

## Funding rounds

- Series E, Dec 10, 2019, $85M — Meritech Capital Partners, OrbiMed Advisors, General Atlantic, NeoMed, CVF Capital Partners, ArrowMark Partners, Redmile Group, SEB Asset Management, Broadfin Capital, Perceptive Advisors, EW Healthcare Partners, JMR Capital Partners, Security Pacific Finance
- Series E, Dec 12, 2016, $35M — Meritech Capital Partners, OrbiMed Advisors, NeoMed, Fjord Ventures, Henry Crown and Company, SEB Asset Management, DNV Capital
- Series D, Sep 4, 2014, $35M — Meritech Capital Partners, OrbiMed Advisors, NeoMed, Fjord Ventures, SEB Asset Management
- Series C, Jun 4, 2013, $18M — OrbiMed Advisors, NeoMed, Themes Investment Partners, Fjord Ventures
- Series C, Jun 28, 2012, $9.2M — OrbiMed Advisors, NeoMed, Fjord Ventures
- Series B, Aug 10, 2011, $3M — NeoMed, Fjord Ventures
- Series B, Dec 1, 2010, $0.8M — NeoMed, Fjord Ventures
- Series B, Mar 23, 2010, $2.1M — NeoMed, Fjord Ventures
- Series A, Nov 26, 2008, $0.5M — NeoMed, Fjord Ventures
- Series A, Jul 17, 2007, $2.5M — NeoMed, Fjord Ventures

## Investors

- NeoMed (https://capitalatlas.ai/funds/neomed) — Series A, Series B, Series C, Series D, Series E
- Fjord Ventures (https://capitalatlas.ai/funds/fjord-ventures) — Series A, Series B, Series C, Series D, Series E
- OrbiMed Advisors (https://capitalatlas.ai/funds/orbimed-advisors) — Series C, Series D, Series E
- Themes Investment Partners (https://capitalatlas.ai/funds/themes-investment-partners) — Series C
- Meritech Capital Partners (https://capitalatlas.ai/funds/meritech-capital-partners) — Series D, Series E
- SEB Asset Management (https://capitalatlas.ai/funds/seb-asset-management) — Series D, Series E
- Henry Crown and Company — Series E
- DNV Capital (https://capitalatlas.ai/funds/dnv-capital) — Series E
- General Atlantic (https://capitalatlas.ai/funds/general-atlantic) — Series E
- CVF Capital Partners — Series E
- ArrowMark Partners — Series E
- Redmile Group (https://capitalatlas.ai/funds/redmile-group) — Series E
- Broadfin Capital — Series E
- Perceptive Advisors (https://capitalatlas.ai/funds/perceptive-advisors) — Series E
- EW Healthcare Partners (https://capitalatlas.ai/funds/ew-healthcare-partners) — Series E
- JMR Capital Partners — Series E
- Security Pacific Finance — Series E